Who is sponsoring NCT04956315?

NCT04956315 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT04956315?

Interventions in NCT04956315: Side-to-side difference (reproducibility), Side-to-side difference (availability), Side-to-side difference (Accuracy).

What condition does NCT04956315 study?

NCT04956315 studies Knee Ligament; Laxity.

Is NCT04956315 still recruiting?

NCT04956315 is currently completed. Last updated 9 July 2021.

Last reviewed 2021-07-09 · How we verify

NCT04956315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Accuracy and Stability of a New Automatic Knee Arthrometer in Diagnosing ACL Rupture

Completed Last updated 9 July 2021

What this trial tests

trial testing Side-to-side difference (reproducibility) in Knee Ligament; Laxity in 421 participants. Completed in 31 December 2020.

Timeline

30 June 2020

Primary endpoint
1 July 2020

31 December 2020

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	421
Start date	30 June 2020
Primary completion	1 July 2020
Estimated completion	31 December 2020
Sites	1 location across China

Drugs / interventions tested

Side-to-side difference (reproducibility)
Side-to-side difference (availability)
Side-to-side difference (Accuracy)

Conditions studied

Knee Ligament; Laxity — all drugs for Knee Ligament; Laxity →

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 45, any sex, with Knee Ligament; Laxity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We introduced an automatic knee arthrometer (AKA) and aimed to evaluate the repeatability and effectiveness thereof in diagnosing ACL rupture compared with the KT-2000.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04956315 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 9 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04956315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing